The Otricathâ„¢ introduces a new perspective on therapy delivery. The platform technology delivers cancer-fighting agents to solid tumors with unparalleled control, predictability, and safety for optimal therapeutic benefit and minimal systemic toxicity.

Learn more

Watch video

The Device

Pilot Studies

The Procedure



NHC, LLC | 2450 Holcombe Blvd., Suite X | Houston, TX 77021

713.839.8600 |